3 Ways to Monitor for RCC Recurrence

Renal cell carcinoma (RCC), the most common type of kidney cancer, is often treated with surgery when caught early. While surgery offers a chance for a cure, it does not guarantee that RCC won’t return. The risk of recurrence or metastasis remains a concern for many who have undergone surgery. This article explores why RCC may come back, how it can spread, and what can be done to reduce the risk and improve outcomes.

Understanding Renal Cell Carcinoma (RCC)

Renal cell carcinoma originates in the lining of the small tubes in the kidney. If detected early, surgery, typically in the form of a nephrectomy (partial or complete removal of the kidney), is a primary treatment option. The aim is to remove the cancerous cells and prevent the cancer from spreading to other parts of the body.

However, RCC can be unpredictable. Even after successful surgery, there is a chance that cancer cells that were too small to be detected might linger and lead to recurrence, either locally in the kidney area or as distant metastases in other organs.

From our partner

Do you still have gout symptoms even though you're taking medication? You’re not alone. The Kadence study is a clinical research study for adults with uncontrolled gout. Learn More

Why RCC May Come Back

RCC recurrence can occur for several reasons, including:

• Microscopic Residual Disease: Cancer cells that are not visible or detectable at the time of surgery can remain in the body. Over time, these cells may grow and become cancerous again.
• Aggressiveness of the Cancer: Some forms of RCC are more aggressive and have a higher likelihood of returning. Factors like the grade of the tumor, size, and whether it has spread to nearby blood vessels or lymph nodes impact recurrence risk.
• Stage at Diagnosis: Higher-stage cancers, especially those that have started to invade surrounding tissues or organs, have a greater risk of recurrence compared to cancers caught at an early stage.
• Genetic Mutations: Certain genetic changes or mutations in the cancer cells may predispose them to spread or grow again, even after the original tumor has been removed.

Where RCC May Spread

RCC is known for its potential to metastasize or spread to other parts of the body. The most common sites for RCC metastasis include:

• Lungs: RCC frequently spreads to the lungs, making them a common site for secondary tumors.
• Bones: Bone metastases can lead to pain, fractures, and other complications.
• Liver: The liver is another common target for RCC spread.
• Brain: Although less common, RCC can also spread to the brain, leading to neurological symptoms.

The recurrence can either be local (near the original tumor site) or distant (in other organs). If the cancer returns, it may still be treatable, but management becomes more complex.

How to Monitor for RCC Recurrence

After surgery, regular follow-up is essential to monitor for recurrence or metastasis. Post-surgery surveillance typically includes:

• Imaging Tests: Periodic CT scans, MRIs, or ultrasounds are commonly used to check for any signs of recurrence or metastasis.
• Blood Tests: Blood tests may help detect changes in kidney function or markers that indicate the return of cancer.
• Physical Exams: Routine physical exams and patient-reported symptoms are important for catching any early signs of recurrence.

The frequency of follow-ups depends on the stage and risk factors associated with the original cancer. Higher-risk patients may require more frequent monitoring compared to those with early-stage cancer.

From our partner

People 16+ years old struggling with lupus: Find out if the PHOENYCS FLY Study may be for you. Study-related care provided at no cost.

Reducing the Risk of RCC Recurrence

While it is impossible to completely eliminate the risk of recurrence, certain steps can be taken to reduce the chances:

• Adjuvant Therapy: After surgery, some patients may be candidates for adjuvant therapy, which includes drugs or treatments designed to target residual cancer cells. For RCC, targeted therapies like tyrosine kinase inhibitors (TKIs) or immune checkpoint inhibitors have shown promise in reducing the risk of recurrence.
• Lifestyle Modifications: Maintaining a healthy lifestyle can also play a role in reducing cancer risk. This includes regular exercise, a balanced diet rich in fruits and vegetables, and avoiding smoking.
• Clinical Trials: For some patients, participation in clinical trials may offer access to new and experimental therapies designed to prevent recurrence.

What to Do if RCC Returns

If RCC does recur, there are still options for treatment. The treatment approach will depend on the extent and location of the recurrence:

• Surgery: In some cases, additional surgery may be recommended to remove the recurrent tumor.
• Targeted Therapy: RCC is often treated with targeted therapies that block specific proteins or pathways that cancer cells need to grow.
• Immunotherapy: Immunotherapy has become an important treatment option for RCC, helping the body’s immune system fight cancer more effectively.
• Radiation Therapy: For metastatic RCC, radiation therapy may be used to treat cancer that has spread to the bones, brain, or other areas.

While the news of recurrence can be overwhelming, advances in treatment continue to improve outcomes for patients with recurrent or metastatic RCC.

For those who have had surgery for RCC, the possibility of recurrence or metastasis is a reality that must be faced. While surgery offers a significant chance for a cure, it does not completely eliminate the risk. Monitoring through regular follow-ups, making lifestyle changes, and considering additional therapies can help reduce the risk and manage any recurrences that may occur.

With continuous advancements in cancer treatment and ongoing research, the outlook for RCC patients continues to improve, even in the face of recurrence. Being proactive and staying informed is crucial for long-term health and well-being.